Calquence Acalabrutinib Capsules 100 Mg Cas No: 1420477-60-6

We are a promising Manufacturer and Supplier of Calquence Acalabrutinib Capsules 100 mg from Amritsar, Punjab, India. Acalabrutinib, also known as ACP-196, is an orally available inhibitor of Brutons tyrosine kinase (BTK) with potential antineoplastic activity. Upon administration, ACP-196 inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This prevents both B-cell activation and BTK-mediated activation of downstream survival pathways. This leads to an inhibition of the growth of malignant B cells that over express BTK. BTK, a member of the src- related BTK / Tec family of cytoplasmic tyrosine kinases, is overexpressed in B-cell malignancies; it plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.

Features :
Exact Mass : 465.19132
Molecular Weight : 465.52
Appearance : White to off-white solid powder
Purity : >99%